These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 22654726)

  • 1. A role for calcineurin in Alzheimer's disease.
    Reese LC; Taglialatela G
    Curr Neuropharmacol; 2011 Dec; 9(4):685-92. PubMed ID: 22654726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimmunomodulation by calcineurin in aging and Alzheimer's disease.
    Reese LC; Taglialatela G
    Aging Dis; 2010 Dec; 1(3):245-53. PubMed ID: 22396864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective induction of calcineurin activity and signaling by oligomeric amyloid beta.
    Reese LC; Zhang W; Dineley KT; Kayed R; Taglialatela G
    Aging Cell; 2008 Dec; 7(6):824-35. PubMed ID: 18782350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synaptic changes in Alzheimer's disease and its models.
    Pozueta J; Lefort R; Shelanski ML
    Neuroscience; 2013 Oct; 251():51-65. PubMed ID: 22687952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Animal Model to Test Reversal of Cognitive Decline Associated with Beta-Amyloid Pathologies.
    Deba F; Peterson S; Hamouda AK
    Methods Mol Biol; 2019; 2011():393-412. PubMed ID: 31273712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation.
    Wu HY; Hudry E; Hashimoto T; Kuchibhotla K; Rozkalne A; Fan Z; Spires-Jones T; Xie H; Arbel-Ornath M; Grosskreutz CL; Bacskai BJ; Hyman BT
    J Neurosci; 2010 Feb; 30(7):2636-49. PubMed ID: 20164348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postsynaptic dysfunction is associated with spatial and object recognition memory loss in a natural model of Alzheimer's disease.
    Ardiles AO; Tapia-Rojas CC; Mandal M; Alexandre F; Kirkwood A; Inestrosa NC; Palacios AG
    Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13835-40. PubMed ID: 22869717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease: synapses gone cold.
    Koffie RM; Hyman BT; Spires-Jones TL
    Mol Neurodegener; 2011 Aug; 6(1):63. PubMed ID: 21871088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
    Pinheiro L; Faustino C
    Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse.
    Morton H; Kshirsagar S; Orlov E; Bunquin LE; Sawant N; Boleng L; George M; Basu T; Ramasubramanian B; Pradeepkiran JA; Kumar S; Vijayan M; Reddy AP; Reddy PH
    Free Radic Biol Med; 2021 Aug; 172():652-667. PubMed ID: 34246776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.
    Rowan MJ; Klyubin I; Wang Q; Anwyl R
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):563-7. PubMed ID: 16042545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
    Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
    Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
    Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linking amyloid-β and tau: amyloid-β induced synaptic dysfunction via local wreckage of the neuronal cytoskeleton.
    Zempel H; Mandelkow EM
    Neurodegener Dis; 2012; 10(1-4):64-72. PubMed ID: 22156588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging beta-amyloid therapies for the treatment of Alzheimer's disease.
    Conway KA; Baxter EW; Felsenstein KM; Reitz AB
    Curr Pharm Des; 2003; 9(6):427-47. PubMed ID: 12570807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.